CKD is silent. NephroSense AI gives it a voice.
Flag hidden CKD risk from labs already in your EHR. No new tests, no new costs, no new workflow. By connecting existing data faster, NephroSense AI helps clinicians prioritize who needs follow-up testing sooner.
CKD Undiagnosed
Analysis Time
The Crisis
The Silent Epidemic
Chronic kidney disease destroys lives quietly. By the time patients feel something is wrong, 70% of kidney function is already gone.
A Global Crisis
850M+people affected by kidney disease worldwide. CKD is projected to become the 5th leading cause of death by 2040.
“Maria is 52. She teaches third grade in Memphis. She has diabetes, high blood pressure, and no idea her kidneys are failing. Her last blood panel had everything we needed to catch it, but nobody connected the dots.”
Maria's story represents millions of Americans whose routine lab results contain early warning signs that go unread.
Americans with CKD
More than diabetes and cancer combined
Are undiagnosed
Symptoms appear only after 70% kidney loss
Dialysis cost per patient
Largely preventable with earlier recognition
The data already exists. The translation is missing.
The Solution
Predict. Explain. Act.
NephroSense AI turns routine lab data into CKD risk scores and clinical guidance, giving clinicians the support they need to intervene early.
Identify Risk in Seconds
Analyzes routine adult bloodwork, vitals, and clinical history to produce a validated CKD risk score in under 10 seconds.
High CKD Risk Detected
Flagged for immediate clinician review
Model Confidence
94%
High agreement
Next Step
Confirm Kidney Workup
38 mg/dL
9.8 g/dL
5.4 mEq/L
Transparent Reasoning
See exactly which biomarkers drive the risk assessment and why, with clear, clinician-friendly explanations. No black box.
Clinical Considerations
Nephrology Referral
High-risk CDS flag plus abnormal routine labs warrant expedited physician review
Blood Pressure Optimization
Target < 130/80 mmHg per KDIGO guidelines
Lifestyle Modifications
Dietary sodium restriction and regular physical activity
Guideline-Aligned Explanations
Receive KDIGO-aligned clinical considerations, feature-level explanations, and downloadable PDF reports built for physician review.
Follow-Up Workflow
Flag hidden CKD risk
Routine-lab clinical decision support identifies adult patients who need closer review.
Clinician reviews flag
Clinician orders confirmatory kidney testing as appropriate after the CDS flag.
Escalate or monitor
Use physician judgment, referral urgency, and repeat labs to guide follow-up.
Workflow
Three Steps. Ten Seconds.
From lab results to clinician-ready decision support in under 10 seconds. No training required, no new infrastructure.
Enter Patient Data
Input adult patient biomarkers manually, upload a lab report (PDF/image), or use a demo scenario. Works with a routine adult lab workup, vitals, and clinical history.
NephroSense AI Analyzes
Our routine-lab clinical decision support workflow reads a routine adult lab workup to flag hidden CKD risk in seconds.
Get Decision-Support Output
Receive CKD risk score, flagged biomarker patterns, feature-level explanations, and a downloadable clinical report for physician review. All in under 10 seconds.
Comparison
Why NephroSense AI
Most kidney disease screening tools require new tests, new hardware, or deliver results you can't explain. NephroSense AI is different.
Early detection of kidney disease should not depend on expensive or specialized testing. NephroSense AI uses routinely available clinical information and an AI-based risk identification algorithm to help recognize individuals at higher risk for kidney disease progression.
| Feature | NephroSense AI | RivalsCompetitors | Standard CKD Workup |
|---|---|---|---|
| No new blood tests needed | |||
| No new hardware required | |||
| Works with existing labs | |||
| Explainable results | |||
| KDIGO-aligned guidance | |||
| Risk triage from routine labs | |||
| EHR integration (FHIR R4) | |||
| Under 10-second results |
Founding Team
Built by scientists, a physician, and AI engineers who've shipped at scale.
MIT · IIT · IIM · KGMU · UCL · NSF: every clinical and engineering skill gap, covered.
Poornima Dubey, PhD
Co-Founder
MIT · HMS · IIT · AI/ML · Nanobiotech · HealthTech
Dr. Nisha Dubey
Co-Founder
KGMU · Clinical Oversight
Amit Jain
Co-Founder
CS/AI Engineer
Global Lead Advisor
Dr. Tushar Vachharajani, MD, MBA
Global Kidney Ambassador
Interventional Nephrologist · ex-Cleveland Clinic
From
Backed by
AI Venture Fund and Studio
Who It's For
Built for the Clinicians Who Need It Most
NephroSense AI is designed for resource-constrained settings where the need is greatest and the impact highest.
FQHCs & Community Health Centers
Screen underserved populations with existing labs. No new tests, no new costs. Designed for the communities most affected by CKD disparities.
Primary Care Physicians
Identify at-risk patients early with explainable results and KDIGO-aligned clinical considerations, without needing nephrology expertise.
Value-Based Care Programs
Batch screen populations, visualize risk distributions, and prioritize interventions. One early catch per clinic per month means $1M+ in avoided costs.
Beyond the point of care, NephroSense AI becomes a risk-intelligence layer for the partners who shape how CKD is studied and detected.
Pharma & Life Sciences
Patient stratification and trial enrichment. Identify and stratify CKD-risk populations for clinical trials and real-world studies -- finding the right patients faster, with explainable, biomarker-level rationale.
Pathology & Diagnostic Labs
Unlock the signal you already hold. Routine results carry the data that predicts CKD. NephroSense AI layers risk intelligence onto your existing panels -- turning every workup into an early-detection opportunity.
Built On
Clinical Foundation
Every prediction is grounded in nationally recognized standards and validated datasets.
USA
Clinical Validation
US adult clinical-cohort validation
KDIGO
Kidney Disease: Improving Global Outcomes
2024 Clinical Practice Guidelines for CKD
CDS
Routine-Lab Clinical Decision Support
Primary CDS workflow reads a routine adult lab workup. Confirmatory kidney testing follows after a patient is flagged.
FHIR R4
Fast Healthcare Interoperability Resources
HL7 standard for EHR data exchange
Validation
Clinically Validated
2024 Aligned
Americans with CKD
Go Undiagnosed
EHR Integration Ready
Clinical Dataset: Feasibility demonstrated on a US adult clinical cohort. The primary workflow reads a routine adult lab workup. Prospective validation planned.
Routine-Lab Workflow: Primary CDS workflow is validated for adults 18+ on a routine adult lab workup; confirmatory kidney testing happens after a patient is flagged.
Ready to Flag Hidden CKD Risk?
Try NephroSense AI now with built-in demo scenarios, or schedule a demo to see how it fits your practice.